NASDAQ:ONCS   OncoSec Medical Incorporated
When, I say that passion goes beyond the imagination, I am led back to this title, believe me, in many years of studies and research in the field of biotechnology, there have been many satisfactions compared to dispaires. Well if I told you that ONCS , in the second half of 2019 and in the first three months of 2020, will officially present TAVO to the world as a trade and product must by them final not only in Australia and New Zealand. but throughout the world as an elite melanoma treatment product, we will wonder if $ 30 per share, given the current RS , will be sufficient ...
If you want to give yourself a space gift, and you can wait, this will reward you at least 15 times in my opinion the current level.
Good trading at all.
Comment: PAY ATTENTION PLS .. allert in action


Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter